Effects of sodium and potassium supplementation on endothelial function: a fully controlled dietary intervention study

Autor: Lieke Gijsbers, Johanna M. Geleijnse, Stephan J. L. Bakker, Casper G. Schalkwijk, Yvo H.A.M. Kusters, James I Dower, Peter C. H. Hollman
Přispěvatelé: Groningen Institute for Organ Transplantation (GIOT), Lifestyle Medicine (LM), Groningen Kidney Center (GKC), Interne Geneeskunde, Promovendi CD, RS: CARIM - R3 - Vascular biology
Rok vydání: 2015
Předmět:
Male
ARTERIAL VASCULAR REACTIVITY
Novel Foods & Agrochains
Brachial Artery
Nutrition and Disease
Medicine (miscellaneous)
Blood Pressure
BLOOD-PRESSURE
Vasomotion
Novel Foods & Agroketens
INCREASE
Voeding en Ziekte
BU Toxicology
Novel Foods & Agrochains

Endothelial dysfunction
Brachial artery
Aged
80 and over

Cross-Over Studies
Nutrition and Dietetics
Endothelin-1
biology
BU Toxicology
Middle Aged
RANDOMIZED CONTROLLED-TRIAL
Vasodilation
Flow-mediated dilation
BU Toxicologie
Novel Foods & Agroketens

Female
Adult
medicine.medical_specialty
BU Toxicologie
Randomised controlled trials
Placebo
Double-Blind Method
BRACHIAL-ARTERY
medicine.artery
Internal medicine
medicine
Humans
Interleukin 8
Aged
VLAG
Global Nutrition
Inflammation
Wereldvoeding
Dose-Response Relationship
Drug

HYPERTENSION
business.industry
Interleukin-8
Sodium
C-reactive protein
Potassium
Dietary

Sodium
Dietary

Endothelial function
ADULTS
medicine.disease
Endothelin 1
DYSFUNCTION
Diet
Endocrinology
Blood pressure
Regional Blood Flow
Dietary Supplements
SALT DIET
Potassium
biology.protein
Endothelium
Vascular

business
Biomarkers
Zdroj: British Journal of Nutrition, 114(9), 1419-1426. Cambridge University Press
British Journal of Nutrition, 114(9), 1419-1426
British Journal of Nutrition 114 (2015) 9
ISSN: 1475-2662
0007-1145
Popis: High Na and low K intakes have adverse effects on blood pressure, which increases the risk for CVD. The role of endothelial dysfunction and inflammation in this pathophysiological process is not yet clear. In a randomised placebo-controlled cross-over study in untreated (pre)hypertensives, we examined the effects of Na and K supplementation on endothelial function and inflammation. During the study period, subjects were provided with a diet that contained 2·4 g/d of Na and 2·3 g/d of K for a 10 460 kJ (2500 kcal) intake. After 1-week run-in, subjects received capsules with supplemental Na (3·0 g/d), supplemental K (2·8 g/d) or placebo, for 4 weeks each, in random order. After each intervention, circulating biomarkers of endothelial function and inflammation were measured. Brachial artery flow-mediated dilation (FMD) and skin microvascular vasomotion were assessed in sub-groups of twenty-two to twenty-four subjects. Of thirty-seven randomised subjects, thirty-six completed the study. Following Na supplementation, serum endothelin-1 was increased by 0·24 pg/ml (95 % CI 0·03, 0·45), but no change was seen in other endothelial or inflammatory biomarkers. FMD and microvascular vasomotion were unaffected by Na supplementation. K supplementation reduced IL-8 levels by 0·28 pg/ml (95 % CI 0·03, 0·53), without affecting other circulating biomarkers. FMD was 1·16 % (95 % CI 0·37, 1·96) higher after K supplementation than after placebo. Microvascular vasomotion was unaffected. In conclusion, a 4-week increase in Na intake increased endothelin-1, but had no effect on other endothelial or inflammatory markers. Increased K intake had a beneficial effect on FMD and possibly IL-8, without affecting other circulating endothelial or inflammatory biomarkers.
Databáze: OpenAIRE